Declined circulating Elabela levels in patients with essential hypertension and its association with impaired vascular function: A preliminary study

Declined circulating Elabela levels in patients with essential hypertension and its association with impaired vascular function: A preliminary study

Background: Elabela (ELA) is a newly identified endogenous ligand of apelin receptor (APJ) which has been confirmed to be implicated in the pathogenesis of hypertension. Previous experiments have revealed the critical role of ELA in eliciting vasodilation and lowering blood pressure. However, the ro...

Full description

Bibliographic Details
Main Authors: Yutao Li, Xulong Yang, Shun Ouyang, Jiang He, Bingbo Yu, Xiufang Lin, Qunying Zhang, Jun Tao
Format: Article
Language:English
Published: Taylor & Francis Group 2020-04-01
Series:Clinical and Experimental Hypertension
Subjects:
elabela
essential hypertension
vascular function
flow-mediated dilation
pulse wave velocity
Online Access:http://dx.doi.org/10.1080/10641963.2019.1619756

Internet

http://dx.doi.org/10.1080/10641963.2019.1619756

Similar Items